{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:00:01Z","timestamp":1791907201674,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012729","name":"Clinical and Translational Science Collaborative of Cleveland, School of Medicine, Case Western Reserve University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007311","name":"Cleveland Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ebiom.2020.102907","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T17:58:08Z","timestamp":1596736688000},"page":"102907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"special_numbering":"C","title":["SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7835-6045","authenticated-orcid":false,"given":"Mina K.","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadashiva","family":"Karnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1896-6423","authenticated-orcid":false,"given":"Joshua","family":"Saef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Barnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Lederman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Tilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feixiong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford V.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8342-4252","authenticated-orcid":false,"given":"Neil","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott J.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith R.","family":"McCrae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin H.","family":"Schmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surafel K.","family":"Gebreselassie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward S.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars G.","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ebiom.2020.102907_bib0001","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.ebiom.2020.102907_bib0002","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102907_bib0003","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","article-title":"Role of the ACE2\/angiotensin 1-7 axis of the renin-angiotensin system in heart failure","volume":"118","author":"Patel","year":"2016","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102907_bib0004","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.13742","article-title":"Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22","volume":"174","author":"Karnik","year":"2017","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102907_bib0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.06.003","article-title":"Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters","volume":"128","author":"Kuba","year":"2010","journal-title":"Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102907_bib0006","doi-asserted-by":"crossref","first-page":"C1169","DOI":"10.1152\/ajpcell.00145.2008","article-title":"MAP kinase\/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides","volume":"295","author":"Gallagher","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102907_bib0007","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11906-014-0420-5","article-title":"ACE2: angiotensin II\/angiotensin- (1-7) balance in cardiac and renal injury","volume":"16","author":"Varagic","year":"2014","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102907_bib0008","doi-asserted-by":"crossref","first-page":"L84","DOI":"10.1152\/ajplung.00071.2009","article-title":"Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia","volume":"297","author":"Jia","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102907_bib0009","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jacc.2008.02.088","article-title":"Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system","volume":"52","author":"Epelman","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ebiom.2020.102907_bib0010","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrd1522","article-title":"Bradykinin receptor ligands: therapeutic perspectives","volume":"3","author":"Marceau","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102907_bib0011","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jth.13194","article-title":"The contact activation and kallikrein\/kinin systems: pathophysiologic and physiologic activities","volume":"14","author":"Schmaier","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102907_bib0012","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin-angiotensin system in cardiovascular disease","volume":"17","author":"Paz Ocaranza","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"17","key":"10.1016\/j.ebiom.2020.102907_bib0013","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1073\/pnas.88.17.7724","article-title":"Expression cloning of a rat B2 bradykinin receptor","volume":"88","author":"McEachern","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"issue":"34","key":"10.1016\/j.ebiom.2020.102907_bib0014","doi-asserted-by":"crossref","first-page":"21583","DOI":"10.1016\/S0021-9258(17)31844-6","article-title":"Expression cloning of a human B1 bradykinin receptor","volume":"269","author":"Menke","year":"1994","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102907_bib0015","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1096\/fj.202000967","article-title":"A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications","volume":"34","author":"Roche","year":"2020","journal-title":"FASEB J"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102907_bib0016","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF02032574","article-title":"Release of cytokines from isolated lung strips by bradykinin","volume":"44","author":"Paegelow","year":"1995","journal-title":"Inflamm Res"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102907_bib0017","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1152\/ajpregu.00535.2002","article-title":"The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction","volume":"285","author":"Schmaier","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102907_bib0018","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1808012","article-title":"Hereditary Angioedema","volume":"382","author":"Busse","year":"2020","journal-title":"N Engl J Med."},{"issue":"2","key":"10.1016\/j.ebiom.2020.102907_bib0019","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.HYP.0000228997.88162.a8","article-title":"Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization","volume":"48","author":"Abadir","year":"2006","journal-title":"Hypertension"},{"issue":"6800","key":"10.1016\/j.ebiom.2020.102907_bib0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/35024095","article-title":"AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration","volume":"407","author":"AbdAlla","year":"2000","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2020.102907_bib0021","article-title":"Beta-Arrestin1 Prevents Preeclampsia by Downregulation of Mechanosensitive AT1-B2 Receptor Heteromers","volume":"176","author":"Quitterer","year":"2019","journal-title":"Cell"},{"issue":"2\u20133","key":"10.1016\/j.ebiom.2020.102907_bib0022","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0162-3109(99)00133-2","article-title":"Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema","volume":"43","author":"Blais","year":"1999","journal-title":"Immunopharmacology"},{"issue":"15","key":"10.1016\/j.ebiom.2020.102907_bib0023","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1182\/blood-2012-09-459156","article-title":"Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-\/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation","volume":"121","author":"Fang","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102907_bib0024","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1182\/blood-2014-01-550285","article-title":"Reduced thrombosis in Klkb1-\/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor","volume":"125","author":"Stavrou","year":"2015","journal-title":"Blood"},{"issue":"7047","key":"10.1016\/j.ebiom.2020.102907_bib0025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.102907_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2019.104350","article-title":"ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway","volume":"113","author":"Ye","year":"2020","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.ebiom.2020.102907_bib0027","doi-asserted-by":"crossref","first-page":"27911","DOI":"10.1038\/srep27911","article-title":"Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1\/2 and NF-kappaB signaling pathways","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2020.102907_bib0028","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pupt.2017.05.002","article-title":"Losartan, a selective antagonist of AT1 receptor, attenuates seawater inhalation induced lung injury via modulating JAK2\/STATs and apoptosis in rat","volume":"45","author":"Li","year":"2017","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.ebiom.2020.102907_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2019.101833","article-title":"Renin-angiotensin-system, a potential pharmacological candidate, in acute respiratory distress syndrome during mechanical ventilation","volume":"58","author":"Wang","year":"2019","journal-title":"Pulm Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102907_bib0030","first-page":"270","article-title":"Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome","volume":"112","author":"Carvalho","year":"1988","journal-title":"J Lab Clin Med"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102907_bib0031","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1172\/JCI110480","article-title":"Studies on the pathogenesis of the adult respiratory distress syndrome","volume":"69","author":"McGuire","year":"1982","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102907_bib0032","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0002-9440(10)65702-1","article-title":"Bradykinin stimulates type II alveolar cells to release neutrophil and monocyte chemotactic activity and inflammatory cytokines","volume":"153","author":"Koyama","year":"1998","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.ebiom.2020.102907_bib0033","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1097\/CCM.0000000000001317","article-title":"Blocking of Kinin B1 receptor: a promising way for the treatment of acute lung injury","volume":"43","author":"Wang","year":"2015","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102907_bib0034","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102907_bib0035","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1128\/JVI.01248-09","article-title":"Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63","volume":"84","author":"Glowacka","year":"2010","journal-title":"J Virol"},{"issue":"19","key":"10.1016\/j.ebiom.2020.102907_bib0036","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.lfs.2005.09.038","article-title":"Age- and gender-related difference of ACE2 expression in rat lung","volume":"78","author":"Xie","year":"2006","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102907_bib0037","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1053\/j.ajkd.2007.11.022","article-title":"Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls","volume":"51","author":"Mizuiri","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102907_bib0038","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13195-016-0217-7","article-title":"Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-beta and tau pathology","volume":"8","author":"Kehoe","year":"2016","journal-title":"Alzheimers Res Ther"},{"issue":"6485","key":"10.1016\/j.ebiom.2020.102907_bib0039","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102907_bib0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102907_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102907_bib0042","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014333","article-title":"FURIN expression in vascular endothelial cells is modulated by a coronary artery disease-associated genetic variant and influences monocyte transendothelial migration","volume":"9","author":"Yang","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102907_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212992","article-title":"Furin, a transcriptional target of NKX2-5, has an essential role in heart development and function","volume":"14","author":"Dupays","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102907_bib0044","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","article-title":"A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells","volume":"78","author":"Hoffmann","year":"2020","journal-title":"Mol Cell"},{"key":"10.1016\/j.ebiom.2020.102907_bib0045","doi-asserted-by":"crossref","unstructured":"Bestle D., Heindl M.R., Limburg H., Van Lam van T., Pilgram O., Moulton H., et\u00a0al. TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets. bioRxiv. 2020.","DOI":"10.1101\/2020.04.15.042085"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102907_bib0046","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01815-18","article-title":"TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection","volume":"93","author":"Iwata-Yoshikawa","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2020.102907_bib0047","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.antiviral.2015.01.011","article-title":"Protease inhibitors targeting coronavirus and filovirus entry","volume":"116","author":"Zhou","year":"2015","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102907_bib0048","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein","volume":"88","author":"Heurich","year":"2014","journal-title":"J Virol"},{"issue":"10229","key":"10.1016\/j.ebiom.2020.102907_bib0049","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.ebiom.2020.102907_bib0050","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1182\/bloodadvances.2019000034","article-title":"Ponatinib treatment promotes arterial thrombosis and hyperactive platelets","volume":"3","author":"Merkulova","year":"2019","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102907_bib0051","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000484257","article-title":"Kallikrein cleaves C3 and activates complement","volume":"10","author":"Irmscher","year":"2018","journal-title":"J Innate Immun"},{"issue":"5\u20136","key":"10.1016\/j.ebiom.2020.102907_bib0052","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2119\/molmed.2009.00160","article-title":"ACE2 activation promotes antithrombotic activity","volume":"16","author":"Fraga-Silva","year":"2010","journal-title":"Mol Med"},{"issue":"7648","key":"10.1016\/j.ebiom.2020.102907_bib0053","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature21706","article-title":"The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors","volume":"544","author":"Lefrancais","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102907_bib0054","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/s41467-019-09607-x","article-title":"The role of platelets in mediating a response to human influenza infection","volume":"10","author":"Koupenova","year":"2019","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102907_bib0055","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1161\/01.HYP.0000034745.98129.EC","article-title":"Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release","volume":"40","author":"Kalinowski","year":"2002","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102907_bib0056","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3565(24)35282-6","article-title":"Novel angiotensin II AT (1) receptor antagonist irbesartan prevents thromboxane A (2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation","volume":"292","author":"Li","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ebiom.2020.102907_bib0057","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41421-020-0147-1","article-title":"Comparative genetic analysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations","volume":"6","author":"Cao","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.ebiom.2020.102907_bib0058","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102907_bib0059","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ebiom.2020.102907_bib0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1624","article-title":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China","author":"Li","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ebiom.2020.102907_bib0061","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.1924","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID-19 infection in a multi-site UK acute hospital trust","author":"Bean","year":"2020","journal-title":"European Journal of Heart failure"},{"key":"10.1016\/j.ebiom.2020.102907_bib0062","doi-asserted-by":"crossref","unstructured":"Rentsch C.T., Kidwai-Khan F., Tate J.P., Park L.S., King J.T., Skanderson M., et\u00a0al. Covid-19 testing, hospital admission, and intensive care among 2,026,227 United States Veterans Aged 54-75 Years. medRxiv. 2020.","DOI":"10.1101\/2020.04.09.20059964"},{"key":"10.1016\/j.ebiom.2020.102907_bib0063","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1855","article-title":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)","author":"Mehta","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"25","key":"10.1016\/j.ebiom.2020.102907_bib0064","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19","volume":"382","author":"Mancia","year":"2020","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.ebiom.2020.102907_bib0065","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19","volume":"382","author":"Reynolds","year":"2020","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ebiom.2020.102907_bib0066","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/eurheartj\/ehaa433","article-title":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study","volume":"41","author":"Gao","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ebiom.2020.102907_bib0067","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.11301","article-title":"Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality","author":"Fosb\u00f8l","year":"2020","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.ebiom.2020.102907_bib0068","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102907_bib0069","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102907_bib0070","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ebiom.2020.102907_bib0071","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.ebiom.2020.102907_bib0072","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.lfs.2018.03.032","article-title":"Idiopathic pulmonary fibrosis (IPF) signaling pathways and protective roles of melatonin","volume":"201","author":"Hosseinzadeh","year":"2018","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102907_bib0073","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.ebiom.2020.102907_bib0074","doi-asserted-by":"crossref","unstructured":"Liu Y., Huang F., Xu J., Yang P., Qin Y., Cao M., et\u00a0al. Anti-hypertensive Angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients. medRxiv. 2020","DOI":"10.1101\/2020.03.20.20039586"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102907_bib0075","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin ii receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ Res"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420302826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420302826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:01:50Z","timestamp":1762455710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420302826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":75,"alternative-id":["S2352396420302826"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102907","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102907","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102907"}}